Friday, March 31, 2017

Oncogene - Table of Contents alert Volume 36 Issue 13

If you are unable to see the message below, click here to view.


The Return of the ChIP Kit

With Diagenode’s ChIP Kit Customizer, buy only the kit-quality reagents that you want.

  • Buy only what you need!  Select from individual components or full kits
  • Validated, ChIP-grade reagents including buffers, beads, controls, antibodies, and more!

Learn more.


Volume 36, Issue 13 (March 2017)

In this issue
Original Articles

Also new

npj Precision Oncology is a new open access, online-only, peer-reviewed journal committed to publishing cutting-edge scientific research in all aspects of precision oncology from basic science to translational applications, to clinical medicine. The journal is part of the Nature Partner Journals series and published in partnership with The Hormel Institute, University of Minnesota.

Explore the benefits of submitting your manuscript.
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
An online-only, open access, multidisciplinary journal dedicated to publishing high-quality original research articles, reviews, editorials, commentaries, and hypothesis generating observations on all areas of breast cancer research. Part of the Nature Partner Journals series, published in partnership with the Breast Cancer Research Foundation.

Now open for submissions >>



Epigenetic therapies by targeting aberrant histone methylome in AML: molecular mechanisms, current preclinical and clinical development OPEN

C T Tsai and C W E So

Oncogene 2017 36: 1753-1759; advance online publication, September 5, 2016; 10.1038/onc.2016.315

Abstract | Full Text

Original Articles


MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation

D-L Qi and D Cobrinik

Oncogene 2017 36: 1760-1769; advance online publication, October 17, 2016; 10.1038/onc.2016.350

Abstract | Full Text

Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells

K E Richards, A E Zeleniak, M L Fishel, J Wu, L E Littlepage and R Hill

Oncogene 2017 36: 1770-1778; advance online publication, September 26, 2016; 10.1038/onc.2016.353

Abstract | Full Text

FERMT1 mediates epithelial–mesenchymal transition to promote colon cancer metastasis via modulation of β-catenin transcriptional activity

C-C Liu, D-L Cai, F Sun, Z-H Wu, B Yue, S-L Zhao, X-S Wu, M Zhang, X-W Zhu, Z-H Peng and D-W Yan

Oncogene 2017 36: 1779-1792; advance online publication, September 19, 2016; 10.1038/onc.2016.339

Abstract | Full Text

Functional redundancy between Apc and Apc2 regulates tissue homeostasis and prevents tumorigenesis in murine mammary epithelium OPEN

C S Daly, P Shaw, L D Ordonez, G T Williams, J Quist, A Grigoriadis, J H Van Es, H Clevers, A R Clarke and K R Reed

Oncogene 2017 36: 1793-1803; advance online publication, October 3, 2016; 10.1038/onc.2016.342

Abstract | Full Text

HDAC1 and HDAC2 integrate the expression of p53 mutants in pancreatic cancer

N Stojanovic, Z Hassan, M Wirth, P Wenzel, M Beyer, C Schäfer, P Brand, A Kroemer, R H Stauber, R M Schmid, A Arlt, A Sellmer, S Mahboobi, R Rad, M Reichert, D Saur, O H Krämer and G Schneider

Oncogene 2017 36: 1804-1815; advance online publication, October 10, 2016; 10.1038/onc.2016.344

Abstract | Full Text

The focal adhesion-associated proteins DOCK5 and GIT2 comprise a rheostat in control of epithelial invasion OPEN

S R Frank, C P Köllmann, J F van Lidth de Jeude, J R Thiagarajah, L H Engelholm, M Frödin and S H Hansen

Oncogene 2017 36: 1816-1828; advance online publication, September 26, 2016; 10.1038/onc.2016.345

Abstract | Full Text

Physical interaction of estrogen receptor with MnSOD: implication in mitochondrial O2.− upregulation and mTORC2 potentiation in estrogen-responsive breast cancer cells

M-U-D Lone, K S Baghel, R K Kanchan, R Shrivastava, S A Malik, B N Tewari, C Tripathi, M P S Negi, V K Garg, M Sharma, M L B Bhatt and S Bhadauria

Oncogene 2017 36: 1829-1839; advance online publication, October 10, 2016; 10.1038/onc.2016.346

Abstract | Full Text

Inhibition of Polo-like kinase 1 during the DNA damage response is mediated through loss of Aurora A recruitment by Bora OPEN

W Bruinsma, M Aprelia, I García-Santisteban, J Kool, Y J Xu and R H Medema

Oncogene 2017 36: 1840-1848; advance online publication, October 10, 2016; 10.1038/onc.2016.347

Abstract | Full Text

Targeting the hedgehog transcription factors GLI1 and GLI2 restores sensitivity to vemurafenib-resistant human melanoma cells OPEN

F Faião-Flores, D K Alves-Fernandes, P C Pennacchi, S Sandri, A L S A Vicente, C Scapulatempo-Neto, V L Vazquez, R M Reis, J Chauhan, C R Goding, K S Smalley and S S Maria-Engler

Oncogene 2017 36: 1849-1861; advance online publication, October 17, 2016; 10.1038/onc.2016.348

Abstract | Full Text

Impairment of DYRK2 augments stem-like traits by promoting KLF4 expression in breast cancer

R Mimoto, Y Imawari, S Hirooka, H Takeyama and K Yoshida

Oncogene 2017 36: 1862-1872; advance online publication, October 10, 2016; 10.1038/onc.2016.349

Abstract | Full Text

Transducin (β)-like 1 X-linked receptor 1 promotes gastric cancer progression via the ERK1/2 pathway OPEN

Q Zhou, X Wang, Z Yu, X Wu, X Chen, J Li, Z Zhu, B Liu and L Su

Oncogene 2017 36: 1873-1886; advance online publication, October 3, 2016; 10.1038/onc.2016.352

Abstract | Full Text

The interaction between acetylation and serine-574 phosphorylation regulates the apoptotic function of FOXO3

Z Li, B Bridges, J Olson and S A Weinman

Oncogene 2017 36: 1887-1898; advance online publication, September 26, 2016; 10.1038/onc.2016.359

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on For event advertising opportunities across the Nature Publishing Group portfolio please contact
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group

No comments: